Sana Biotechnology SANA Enterprise value

Enterprise value at other companies

Bristol-Myers SquibbBMY

$152.27B+14.9%

Vertex PharmaceuticalsVRTX

$120.2B+7.2%

Gilead SciencesGILD

$179.93B+17.5%

CRISPR TherapeuticsCRSP

$4.93B+69.8%

Allogene TherapeuticsALLO

$635.27M+79.8%

Ginkgo BioworksDNA

$879.46M+22.9%

FAQ

What is Sana Biotechnology's enterprise value?

Sana Biotechnology (SANA) reported enterprise value of $760.1M in Q1 2026.

How has Sana Biotechnology's enterprise value changed year-over-year?

Sana Biotechnology's enterprise value increased by 103.7% year-over-year, from $373.22M to $760.1M.

What is the long-term trend for Sana Biotechnology's enterprise value?

Over 4 years (2021 to 2025), Sana Biotechnology's enterprise value has grown at a -20.5% compound annual growth rate (CAGR), from $2.74B to $1.09B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.